What is the role of hematopoietic cell transplantation in the treatment of non-Hodgkin lymphoma/B-cell lymphoma?

Updated: Feb 23, 2021
  • Author: Mohammad Muhsin Chisti, MD, FACP; Chief Editor: Emmanuel C Besa, MD  more...
  • Print

Patients with relapsed or refractory DLBC should be considered for autologous hematopoietic cell transplantation (HCT) when CAR T-cell therapy is not available. For transplant-ineligible patients, the goal of care should be limiting the symptoms. CAR T-cell therapy can be administered. Such patients can participate in newer clinical trials. [27]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!